For people with vitiligo and their caregivers
What this page helps you do
A photograph records what a lighter patch looked like at one moment. Learn what a clinician may assess, what to record before a visit, and which questions can help you leave with a clearer explanation.
- Your task
- Find the short answer, note what depends on your situation, and choose whether a conversation is needed.
- The clinician boundary
- Diagnosis, assessment of activity and body sites, prescribing, monitoring, and personalized treatment decisions belong to a qualified clinician.
Is this vitiligo?
A visual comparison can organize questions—not diagnose
We do not diagnose from photos, and neither should a forum. A camera can hide or exaggerate color and borders. A qualified clinician needs the history and a proper skin examination.
Pigment loss
May look fully white with a clearer edge.
Vitiligo is one possible cause, but appearance alone cannot confirm it.
Surface change
Scale, dryness, or itch may point the exam toward another cause.
A clinician may consider a surface yeast rash or an eczema-related change.
After inflammation
A lighter area may follow a rash, injury, or other skin inflammation.
The earlier skin event and how the area changed can help the exam.
Long-standing pattern
A stable lighter patch present from early life may have a different explanation.
History over time matters more than matching one online photograph.
A dermatologist may use a Wood lamp as one part of the exam. A home light, app, photograph, or checklist cannot replace that examination.
Evidence and limits
Confidence: reasonably supported · Checked:
- Vitiligo: Diagnosis, Treatment, and Steps to Take — National Institute of Arthritis and Musculoskeletal and Skin Diseases
Published . Supports diagnosis through history and examination, possible clinician use of a Wood lamp, and the chalky-bright appearance of pigment loss under that examination light.
Limit: It does not support diagnosis from a photograph, a home lamp, or a visual checklist.
- Guidelines for narrowband ultraviolet B phototherapy — British Association of Dermatologists and British Photodermatology Group
Published . Supports NB-UVB uses, accurate light measurement, quality checks, home-treatment governance, and condition-specific care.
Limit: It does not choose a device or care setting for one person and SteadySkin does not reproduce treatment schedules from it.
Does a white patch mean I have vitiligo?
Short answerNo. Skin can look lighter or white for several reasons, and appearance alone cannot confirm which one is present. An unexplained color change deserves a qualified clinical assessment rather than a diagnosis from a photograph, search result, or app. Evidence Evidence
More detail
Vitiligo causes loss of pigment, but other conditions and changes after inflammation or injury can also produce lighter areas. The useful first question is not “Does this look exactly like someone else’s vitiligo?” but “What findings would distinguish the possible causes in my case?”
What depends on your situation
Color, border shape, body site, or symmetry may give a clinician clues, but none of those features is a stand-alone home test. Images can also hide or exaggerate contrast because cameras, lighting, and surrounding skin color differ.
How is vitiligo usually assessed?
Short answerDiagnosis usually starts with the story of the color change and an examination of the skin. A clinician may ask when it was first noticed, whether it has changed, what areas are involved, and whether there is relevant personal or family medical history. Evidence Evidence Evidence
More detail
Government and dermatology guidance describe medical history and a thorough skin examination as the core of assessment. Examining the surrounding skin, hair, and the distribution of patches can help the clinician decide whether the pattern is consistent with vitiligo or needs a different explanation.
What depends on your situation
A first visit does not always produce a final label. Very early, isolated, or atypical changes may need follow-up because the pattern becomes clearer only when the clinician can compare findings across visits.
What does a Wood’s lamp add?
Short answerA dermatologist may use a Wood’s lamp as one part of the examination. It can make areas of pigment loss easier to see, but it does not turn a photograph or a lamp at home into a reliable diagnostic test. Evidence Evidence
More detail
NIAMS and the American Academy of Dermatology describe the Wood’s lamp as a clinical examination tool that can help a clinician inspect affected skin under specialized light. Its value comes from interpreting that view alongside the history and the rest of the examination.
What depends on your situation
Not every person needs this examination, and the lamp alone does not answer every differential-diagnosis question. Consumer ultraviolet lights and phone images are not substitutes for the clinician’s equipment, technique, and interpretation.
Will I need blood tests, an eye exam, or a biopsy?
Short answerPossibly, but these are not automatic steps for every lighter patch. A clinician may consider additional testing when the history, examination, or possible associated conditions make it useful. Evidence Evidence
More detail
NIAMS lists blood testing for associated autoimmune disease, an eye examination, and skin biopsy among tests that may be used in a vitiligo evaluation. The purpose should be explicit: each test ought to answer a specific question raised by the clinical assessment.
What depends on your situation
The useful tests depend on your history and examination. Each test should answer a specific clinical question; more testing is not automatically a better evaluation.
What should I record before seeking care?
Short answerWrite down where you first noticed the change, what has changed since then, and any relevant skin events, symptoms, medicines, personal history, or family history. A few consistently framed photographs can document your observations, but they are a record for the conversation—not proof of a diagnosis. Evidence Evidence
More detail
Classification and management guidance distinguishes the distribution and apparent activity of vitiligo because those descriptions help clinicians communicate about what they are seeing. Bringing a short chronology and the questions that matter to you can make that assessment easier to understand.
What depends on your situation
A photograph cannot reliably show every clinically important feature or predict what a patch will do next. If the clinician remains uncertain, the appropriate next step may be observation, further examination, testing, or referral rather than a confident label.
Questions that can change the next decision
- For your clinicianWhat would make you reconsider the diagnosis?Saving keeps this on your device and needs JavaScript, which is off in this browser.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- Journal of the European Academy of Dermatology and VenereologyRegulatory / guideline · not independentRelevant relationship disclosed
- Published
- 2023-09-25
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
Why the independence label says this: The journal is the publisher. This label refers to extensive author relationships disclosed for the recommendation, not to the journal itself.
What this source supports
It supports current expert-consensus terminology, clinical assessment, disease-activity evaluation, treatment-goal discussion, and shared decision-making.
What it does not support
It is not independent comparative proof. It cannot diagnose a reader from a description or photograph.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- British Journal of Dermatology (Eleftheriadou V, et al.)Regulatory / guideline · independentIndependent source
- Published
- 2022-01-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports the clinical history and assessment domains, evaluation of associated autoimmune conditions, its recommendation for thyroid function and antithyroid antibody screening, current classification context, treatment-option map, psychosocial assessment, medical photography and the limits of pediatric evidence.
What it does not support
It was designed for UK care and reviewed literature through May 2019; it does not establish a universal testing plan, prescribe an individual plan, or establish current US labeling or coverage.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- National Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient education · independentIndependent source
- Published
- 2022-10-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports a patient-facing description of clinician diagnosis using history and examination, possible use of a Wood lamp and selected tests, broad treatment categories, variable response and whole-person support.
What it does not support
It is educational context, not primary efficacy evidence, an online diagnostic method or a universal testing checklist.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- Pigment Cell & Melanoma Research (Ezzedine K, et al.)Regulatory / guideline · independentIndependent source
- Published
- 2012-05-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports separating segmental vitiligo from nonsegmental forms and recognizing mixed and initially unclassified presentations.
What it does not support
Classification is a clinical and longitudinal judgment; the consensus does not support self-classification from symmetry, one patch or a photograph, and it does not predict an individual response.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- American Academy of DermatologyPatient education · not independentIndependence not established
- Published
- 2026-04-15
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports current US patient-language context that lighter patches have multiple causes, dermatologists diagnose vitiligo from history and examination, treatment is optional and several broad management paths exist.
What it does not support
The page acknowledges support from Incyte Dermatology, so it does not independently establish drug efficacy or comparative superiority.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.